Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zhenbo Tu, Ph.D.

Concepts (83)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Zhenbo Tu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Zhenbo Tu has written about over time.
Chemokines, CC, 1 publications between 2016 and 2016, average publication date February 2016. Receptors, CCR, 1 publications between 2016 and 2016, average publication date February 2016. Epithelial-Mesenchymal Transition, 1 publications between 2016 and 2016, average publication date December 2016. Receptors, CXCR4, 1 publications between 2016 and 2016, average publication date December 2016. Neoplastic Stem Cells, 2 publications between 2016 and 2019, average publication date April 2018. Cell Cycle, 3 publications between 2016 and 2020, average publication date July 2018. Lung Neoplasms, 3 publications between 2016 and 2022, average publication date July 2018. Interleukin-17, 1 publications between 2018 and 2018, average publication date October 2018. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 1 publications between 2018 and 2018, average publication date October 2018. Cell Transformation, Neoplastic, 3 publications between 2016 and 2022, average publication date January 2020. CCAAT-Enhancer-Binding Proteins, 1 publications between 2020 and 2020, average publication date June 2020. Ubiquitin-Protein Ligases, 2 publications between 2020 and 2021, average publication date January 2021. Mesenchymal Stem Cells, 1 publications between 2022 and 2022, average publication date September 2022.

To see the data from this visualization as text, click here.
Tu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.